ProKidney
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ProKidney and other ETFs, options, and stocks.About PROK
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD.
CEOBruce Culleton
CEOBruce Culleton
Employees204
Employees204
HeadquartersWinston-Salem, North Carolina
HeadquartersWinston-Salem, North Carolina
Founded2015
Founded2015
Employees204
Employees204
PROK Key Statistics
Market cap637.77M
Market cap637.77M
Price-Earnings ratio-3.99
Price-Earnings ratio-3.99
Dividend yield—
Dividend yield—
Average volume1.22M
Average volume1.22M
High today$2.21
High today$2.21
Low today$2.12
Low today$2.12
Open price$2.17
Open price$2.17
Volume125.50K
Volume125.50K
52 Week high$7.13
52 Week high$7.13
52 Week low$0.4603
52 Week low$0.4603
Stock Snapshot
With a market cap of 637.77M, ProKidney(PROK) trades at $2.12. The stock has a price-to-earnings ratio of -3.99.
On 2025-12-11, ProKidney(PROK) stock traded between a low of $2.12 and a high of $2.21. Shares are currently priced at $2.12, which is 0.0% above the low and -4.1% below the high.
The ProKidney(PROK)'s current trading volume is 125.5K, compared to an average daily volume of 1.22M.
During the past year, ProKidney(PROK) stock moved between $0.46 at its lowest and $7.13 at its peak.
During the past year, ProKidney(PROK) stock moved between $0.46 at its lowest and $7.13 at its peak.
Analyst ratings
50%
of 6 ratingsBuy
50%
Hold
33.3%
Sell
16.7%
People also own
Based on the portfolios of people who own PROK. This list is generated using Robinhood data, and it’s not a recommendation.